BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24452457)

  • 1. Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress.
    Bahmani B; Roudkenar MH; Halabian R; Jahanian-Najafabadi A; Amiri F; Jalili MA
    Cell Stress Chaperones; 2014 Sep; 19(5):685-93. PubMed ID: 24452457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments.
    Halabian R; Tehrani HA; Jahanian-Najafabadi A; Habibi Roudkenar M
    Cell Stress Chaperones; 2013 Nov; 18(6):785-800. PubMed ID: 23620204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-culture of bone marrow-derived mesenchymal stem cells overexpressing lipocalin 2 with HK-2 and HEK293 cells protects the kidney cells against cisplatin-induced injury.
    Halabian R; Roudkenar MH; Jahanian-Najafabadi A; Hosseini KM; Tehrani HA
    Cell Biol Int; 2015 Feb; 39(2):152-63. PubMed ID: 25049146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells.
    Lu M; Xia L; Liu YC; Hochman T; Bizzari L; Aruch D; Lew J; Weinberg R; Goldberg JD; Hoffman R
    Blood; 2015 Aug; 126(8):972-82. PubMed ID: 26022238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin-2 inhibits osteoclast formation by suppressing the proliferation and differentiation of osteoclast lineage cells.
    Kim HJ; Yoon HJ; Yoon KA; Gwon MR; Jin Seong S; Suk K; Kim SY; Yoon YR
    Exp Cell Res; 2015 Jun; 334(2):301-9. PubMed ID: 25814363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells.
    Ho PJ; Yen ML; Tang BC; Chen CT; Yen BL
    Antioxid Redox Signal; 2013 May; 18(15):1895-905. PubMed ID: 23088254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow.
    Kundrotas G; Gasperskaja E; Slapsyte G; Gudleviciene Z; Krasko J; Stumbryte A; Liudkeviciene R
    Oncotarget; 2016 Mar; 7(10):10788-802. PubMed ID: 26910916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone.
    Costa D; Biticchi R; Negrini S; Tasso R; Cancedda R; Descalzi F; Pennesi G; Tavella S
    Cytokine; 2010 Jul; 51(1):47-52. PubMed ID: 20362461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhibit liver metastasis in nude mice.
    Harati MD; Amiri F; Jaleh F; Mehdipour A; Harati MD; Molaee S; Bahadori M; Shokrgozar MA; Jalili MA; Roudkenar MH
    Tumour Biol; 2015 Aug; 36(8):6011-8. PubMed ID: 25740061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Regulatory Mechanisms Underlying Bone Marrow Mesenchymal Stem Cell Senescence During Cell Passages.
    Iwata T; Mizuno N; Ishida S; Kajiya M; Nagahara T; Kaneda-Ikeda E; Yoshioka M; Munenaga S; Ouhara K; Fujita T; Kawaguchi H; Kurihara H
    Cell Biochem Biophys; 2021 Jun; 79(2):321-336. PubMed ID: 33559812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin 2 promotes breast cancer progression.
    Yang J; Bielenberg DR; Rodig SJ; Doiron R; Clifton MC; Kung AL; Strong RK; Zurakowski D; Moses MA
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3913-8. PubMed ID: 19237579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the periphery to the brain: Lipocalin-2, a friend or foe?
    Ferreira AC; Dá Mesquita S; Sousa JC; Correia-Neves M; Sousa N; Palha JA; Marques F
    Prog Neurobiol; 2015 Aug; 131():120-36. PubMed ID: 26159707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
    Nadeau S; Cheng A; Colmegna I; Rodier F
    Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery SMC resistance to apoptosis.
    Wang G; Liu X; Meng L; Liu S; Wang L; Li J; Cui C; Meng J; Hu S; Wei Y
    Int J Biol Sci; 2014; 10(7):798-806. PubMed ID: 25076856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
    Borkham-Kamphorst E; Drews F; Weiskirchen R
    Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipocalin 2: a multifaceted modulator of human cancer.
    Yang J; Moses MA
    Cell Cycle; 2009 Aug; 8(15):2347-52. PubMed ID: 19571677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipogenic and Osteogenic Differentiation of In Vitro Aged Human Mesenchymal Stem Cells.
    Ogando CR; Barabino GA; Yang YK
    Methods Mol Biol; 2019; 2045():107-117. PubMed ID: 30484146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells from amniotic fluid are less prone to senescence compared to those obtained from bone marrow: An in vitro study.
    Alessio N; Pipino C; Mandatori D; Di Tomo P; Ferone A; Marchiso M; Melone MAB; Peluso G; Pandolfi A; Galderisi U
    J Cell Physiol; 2018 Nov; 233(11):8996-9006. PubMed ID: 29904927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.